| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | CAPN12 VLDLR SPOCK1 GNPTAB CAPN3 GAS6 NOTCH2NLA ACTN1 PKD1L2 DLL1 NOTCH2NLC LRP1B SYT10 LDLR CRB1 NELL1 NOTCH2NLB JAG1 LRP1 LRP2 UMOD NOTCH1 NOTCH2 | 1.03e-11 | 749 | 108 | 23 | GO:0005509 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.67e-10 | 16 | 108 | 6 | GO:0005041 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 8.26e-10 | 85 | 108 | 9 | GO:0038024 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.11e-09 | 21 | 108 | 6 | GO:0030228 | |
| GeneOntologyMolecularFunction | Notch binding | 3.10e-07 | 27 | 108 | 5 | GO:0005112 | |
| GeneOntologyMolecularFunction | virus receptor activity | 6.73e-06 | 85 | 108 | 6 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 7.20e-06 | 86 | 108 | 6 | GO:0140272 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 3.72e-05 | 35 | 108 | 4 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 3.72e-05 | 35 | 108 | 4 | GO:0071814 | |
| GeneOntologyMolecularFunction | integrin binding | 4.67e-05 | 175 | 108 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 1.18e-04 | 18 | 108 | 3 | GO:0030169 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.66e-04 | 51 | 108 | 4 | GO:0043394 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor activity | 1.73e-04 | 4 | 108 | 2 | GO:0030229 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 4.09e-04 | 27 | 108 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RANBP2 FN1 PPP2R2D SPOCK1 CAPN3 GAS6 NAIP CD55 NCF2 PTN PPP2R2B PPP2R2C EGFR NOTCH1 TBCD SORL1 SOS1 SOS2 | 5.75e-04 | 1418 | 108 | 18 | GO:0030234 |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 1.85e-03 | 12 | 108 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 1.85e-03 | 12 | 108 | 2 | GO:0016175 | |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 2.13e-03 | 100 | 108 | 4 | GO:0019888 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.29e-03 | 102 | 108 | 4 | GO:0001540 | |
| GeneOntologyMolecularFunction | sodium ion binding | 2.53e-03 | 14 | 108 | 2 | GO:0031402 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 3.37e-07 | 53 | 108 | 6 | GO:0045747 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.39e-06 | 5 | 108 | 3 | GO:1905167 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | VLDLR SFTPD FOLR1 LDLRAD3 DLL1 LRP1B LDLR SCARF1 LRP1 LRP2 SORL1 | 1.58e-06 | 337 | 108 | 11 | GO:0006898 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | FN1 SPOCK1 GAS6 ACTN1 ITGB7 PTN LIMS1 JAG1 LRP1 FGG NOTCH1 TBCD | 1.62e-06 | 410 | 108 | 12 | GO:0031589 |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 2.30e-06 | 114 | 108 | 7 | GO:0008593 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 2.76e-06 | 6 | 108 | 3 | GO:0002085 | |
| GeneOntologyBiologicalProcess | gliogenesis | FN1 LAMA2 DLL1 LDLR CRB1 PTN EGFR LRP1 LRP2 NOTCH1 NOTCH2 SOS1 | 2.99e-06 | 435 | 108 | 12 | GO:0042063 |
| GeneOntologyBiologicalProcess | symbiont entry into host cell | 3.02e-06 | 169 | 108 | 8 | GO:0046718 | |
| GeneOntologyBiologicalProcess | symbiont entry into host | 4.08e-06 | 176 | 108 | 8 | GO:0044409 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 4.81e-06 | 7 | 108 | 3 | GO:1904352 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 5.81e-06 | 131 | 108 | 7 | GO:0030510 | |
| GeneOntologyBiologicalProcess | endocytosis | NPC1 VLDLR SFTPD FOLR1 GAS6 MYO18A NCF2 LDLRAD3 DLL1 LRP1B LDLR CD209 SCARF1 LRP1 LRP2 SORL1 | 6.24e-06 | 827 | 108 | 16 | GO:0006897 |
| GeneOntologyBiologicalProcess | regeneration | 7.18e-06 | 252 | 108 | 9 | GO:0031099 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 7.29e-06 | 321 | 108 | 10 | GO:0010001 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 7.65e-06 | 254 | 108 | 9 | GO:0010810 | |
| GeneOntologyBiologicalProcess | regulation of pro-B cell differentiation | 7.67e-06 | 8 | 108 | 3 | GO:2000973 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 8.87e-06 | 92 | 108 | 6 | GO:0048844 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | NOTCH2NLA DLL1 NOTCH2NLC NOTCH2NLB CBFA2T2 JAG1 NOTCH1 NOTCH2 | 1.49e-05 | 210 | 108 | 8 | GO:0007219 |
| GeneOntologyBiologicalProcess | loop of Henle development | 1.63e-05 | 10 | 108 | 3 | GO:0072070 | |
| GeneOntologyBiologicalProcess | distal tubule development | 1.63e-05 | 10 | 108 | 3 | GO:0072017 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.92e-05 | 285 | 108 | 9 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.97e-05 | 286 | 108 | 9 | GO:0097485 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 1.98e-05 | 63 | 108 | 5 | GO:0007157 | |
| GeneOntologyBiologicalProcess | neuron development | ACSL6 VLDLR FN1 SPOCK1 FOLR1 LAMA2 LRTM2 GBA2 CRB1 SCARF1 PTN MEGF9 EGFR CBFA2T2 SEMA3B LRP1 LRP2 NOTCH1 NOTCH2 TBCD SOS1 | 2.01e-05 | 1463 | 108 | 21 | GO:0048666 |
| GeneOntologyBiologicalProcess | biological process involved in interaction with host | 2.69e-05 | 228 | 108 | 8 | GO:0051701 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 2.97e-05 | 12 | 108 | 3 | GO:1905165 | |
| GeneOntologyBiologicalProcess | regulation of lymphoid progenitor cell differentiation | 2.97e-05 | 12 | 108 | 3 | GO:1905456 | |
| GeneOntologyBiologicalProcess | axon development | FN1 FOLR1 LAMA2 LRTM2 SCARF1 PTN MEGF9 SEMA3B LRP1 LRP2 NOTCH1 NOTCH2 SOS1 | 3.12e-05 | 642 | 108 | 13 | GO:0061564 |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 3.29e-05 | 171 | 108 | 7 | GO:0048593 | |
| GeneOntologyBiologicalProcess | pro-B cell differentiation | 3.84e-05 | 13 | 108 | 3 | GO:0002328 | |
| GeneOntologyBiologicalProcess | import into cell | NPC1 ACSL6 VLDLR SFTPD FOLR1 GAS6 MYO18A NCF2 LDLRAD3 DLL1 LRP1B LDLR CD209 SCARF1 LRP1 LRP2 SORL1 | 4.17e-05 | 1074 | 108 | 17 | GO:0098657 |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 4.33e-05 | 74 | 108 | 5 | GO:0010812 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 4.85e-05 | 124 | 108 | 6 | GO:0007229 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 4.87e-05 | 14 | 108 | 3 | GO:1904350 | |
| GeneOntologyBiologicalProcess | left/right axis specification | 4.87e-05 | 14 | 108 | 3 | GO:0070986 | |
| GeneOntologyBiologicalProcess | regulation of timing of cell differentiation | 6.07e-05 | 15 | 108 | 3 | GO:0048505 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 6.15e-05 | 412 | 108 | 10 | GO:0090287 | |
| GeneOntologyBiologicalProcess | artery development | 7.17e-05 | 133 | 108 | 6 | GO:0060840 | |
| GeneOntologyBiologicalProcess | respiratory burst | 7.50e-05 | 43 | 108 | 4 | GO:0045730 | |
| GeneOntologyBiologicalProcess | viral life cycle | 7.55e-05 | 340 | 108 | 9 | GO:0019058 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 8.05e-05 | 197 | 108 | 7 | GO:0030509 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 8.12e-05 | 3 | 108 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 8.82e-05 | 347 | 108 | 9 | GO:0090092 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell apoptotic process | 8.92e-05 | 86 | 108 | 5 | GO:1904036 | |
| GeneOntologyBiologicalProcess | regulation of development, heterochronic | 9.00e-05 | 17 | 108 | 3 | GO:0040034 | |
| GeneOntologyBiologicalProcess | positive regulation of axon regeneration | 9.00e-05 | 17 | 108 | 3 | GO:0048680 | |
| GeneOntologyBiologicalProcess | biological process involved in symbiotic interaction | 9.62e-05 | 351 | 108 | 9 | GO:0044403 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | FN1 SPOCK1 SFTPD LAMA2 CD55 DLL1 CD209 PTN LIMS1 JAG1 LRP1 ZFHX3 FGG NOTCH1 TBCD | 9.69e-05 | 927 | 108 | 15 | GO:0030155 |
| GeneOntologyBiologicalProcess | eye morphogenesis | 1.00e-04 | 204 | 108 | 7 | GO:0048592 | |
| GeneOntologyBiologicalProcess | astrocyte development | 1.07e-04 | 47 | 108 | 4 | GO:0014002 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection regeneration | 1.08e-04 | 18 | 108 | 3 | GO:0070572 | |
| GeneOntologyBiologicalProcess | retina morphogenesis in camera-type eye | 1.11e-04 | 90 | 108 | 5 | GO:0060042 | |
| GeneOntologyBiologicalProcess | neuron projection development | ACSL6 VLDLR FN1 SPOCK1 FOLR1 LAMA2 LRTM2 SCARF1 PTN MEGF9 EGFR CBFA2T2 SEMA3B LRP1 LRP2 NOTCH1 NOTCH2 SOS1 | 1.17e-04 | 1285 | 108 | 18 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of endocytosis | 1.31e-04 | 213 | 108 | 7 | GO:0045807 | |
| GeneOntologyBiologicalProcess | response to BMP | 1.39e-04 | 215 | 108 | 7 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 1.39e-04 | 215 | 108 | 7 | GO:0071773 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | VLDLR FN1 LAMA2 LRTM2 PTN MEGF9 SEMA3B LRP1 LRP2 NOTCH1 NOTCH2 TBCD SOS1 | 1.46e-04 | 748 | 108 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 1.49e-04 | 20 | 108 | 3 | GO:0003184 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SFTPD SCARF2 CD55 FNDC3A ACTN1 ITGB7 CD209 CRB1 SCARF1 LIMS1 EGFR JAG1 UMOD FGG MEGF11 NOTCH1 | 1.50e-04 | 1077 | 108 | 16 | GO:0098609 |
| GeneOntologyBiologicalProcess | positive regulation of phagocytosis | 1.73e-04 | 99 | 108 | 5 | GO:0050766 | |
| GeneOntologyBiologicalProcess | response to growth factor | FOLR1 GAS6 DLL1 TRIM33 UBE2O EGFR LRP1 LRP2 ZFHX3 FST NOTCH1 NOTCH2 SORL1 SOS1 | 2.08e-04 | 883 | 108 | 14 | GO:0070848 |
| GeneOntologyBiologicalProcess | cholesterol metabolic process | 2.19e-04 | 163 | 108 | 6 | GO:0008203 | |
| GeneOntologyBiologicalProcess | astrocyte differentiation | 2.28e-04 | 105 | 108 | 5 | GO:0048708 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 2.41e-04 | 166 | 108 | 6 | GO:0098773 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 2.61e-04 | 24 | 108 | 3 | GO:0003177 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 2.61e-04 | 24 | 108 | 3 | GO:1905146 | |
| GeneOntologyBiologicalProcess | negative regulation of inner ear receptor cell differentiation | 2.69e-04 | 5 | 108 | 2 | GO:2000981 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 2.69e-04 | 5 | 108 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | behavioral response to chemical pain | 2.69e-04 | 5 | 108 | 2 | GO:0061366 | |
| GeneOntologyBiologicalProcess | behavioral response to formalin induced pain | 2.69e-04 | 5 | 108 | 2 | GO:0061368 | |
| GeneOntologyBiologicalProcess | compartment pattern specification | 2.69e-04 | 5 | 108 | 2 | GO:0007386 | |
| GeneOntologyBiologicalProcess | negative regulation of inner ear auditory receptor cell differentiation | 2.69e-04 | 5 | 108 | 2 | GO:0045608 | |
| GeneOntologyBiologicalProcess | negative regulation of mechanoreceptor differentiation | 2.69e-04 | 5 | 108 | 2 | GO:0045632 | |
| GeneOntologyBiologicalProcess | positive regulation of protein transport | 2.76e-04 | 319 | 108 | 8 | GO:0051222 | |
| GeneOntologyBiologicalProcess | nephron tubule development | 2.84e-04 | 110 | 108 | 5 | GO:0072080 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | VLDLR FN1 LAMA2 LRTM2 PTN MEGF9 EGFR SEMA3B LRP1 LRP2 NOTCH1 NOTCH2 SOS1 | 2.88e-04 | 802 | 108 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | positive regulation of Ras protein signal transduction | 2.95e-04 | 25 | 108 | 3 | GO:0046579 | |
| GeneOntologyBiologicalProcess | secondary alcohol metabolic process | 3.30e-04 | 176 | 108 | 6 | GO:1902652 | |
| GeneOntologyBiologicalProcess | lymphoid progenitor cell differentiation | 3.32e-04 | 26 | 108 | 3 | GO:0002320 | |
| GeneOntologyBiologicalProcess | sterol metabolic process | 3.41e-04 | 177 | 108 | 6 | GO:0016125 | |
| GeneOntologyBiologicalProcess | inflammatory response | CYBB USP18 FN1 NAIP LDLR ADCY8 PTN NLRP10 EGFR NFKBIB SCN9A LRP1 UMOD NOTCH1 NOTCH2 | 3.48e-04 | 1043 | 108 | 15 | GO:0006954 |
| GeneOntologyBiologicalProcess | blood vessel development | CYBB GGNBP2 FN1 FOLR1 DLL1 LDLR PTN JAG1 LRP1 LRP2 NOTCH1 NOTCH2 ERVFRD-1 SOS1 | 3.49e-04 | 929 | 108 | 14 | GO:0001568 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | VLDLR FN1 LAMA2 LRTM2 PTN MEGF9 EGFR SEMA3B LRP1 LRP2 NOTCH1 NOTCH2 SOS1 | 3.52e-04 | 819 | 108 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | renal tubule development | 3.63e-04 | 116 | 108 | 5 | GO:0061326 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 3.75e-04 | 515 | 108 | 10 | GO:0050767 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | VLDLR FN1 LAMA2 LRTM2 PTN MEGF9 EGFR SEMA3B LRP1 LRP2 NOTCH1 NOTCH2 SOS1 | 3.81e-04 | 826 | 108 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | chemotaxis | 3.87e-04 | 517 | 108 | 10 | GO:0006935 | |
| GeneOntologyBiologicalProcess | taxis | 3.99e-04 | 519 | 108 | 10 | GO:0042330 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 4.02e-04 | 6 | 108 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | ciliary body morphogenesis | 4.02e-04 | 6 | 108 | 2 | GO:0061073 | |
| GeneOntologyBiologicalProcess | pulmonary artery morphogenesis | 4.02e-04 | 6 | 108 | 2 | GO:0061156 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 4.02e-04 | 6 | 108 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | arterial endothelial cell differentiation | 4.02e-04 | 6 | 108 | 2 | GO:0060842 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 4.05e-04 | 426 | 108 | 9 | GO:0043010 | |
| GeneOntologyBiologicalProcess | protein catabolic process in the vacuole | 4.16e-04 | 28 | 108 | 3 | GO:0007039 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 4.37e-04 | 625 | 108 | 11 | GO:0051960 | |
| GeneOntologyBiologicalProcess | embryo development | MBTD1 GGNBP2 FN1 FOLR1 LAMA2 DLL1 NSUN2 LRP1B XAB2 LIMS1 EGFR JAG1 LRP2 POFUT2 NOTCH1 NOTCH2 ERVFRD-1 SOS1 | 4.59e-04 | 1437 | 108 | 18 | GO:0009790 |
| GeneOntologyBiologicalProcess | tissue remodeling | 4.61e-04 | 262 | 108 | 7 | GO:0048771 | |
| GeneOntologyBiologicalProcess | astrocyte activation | 4.62e-04 | 29 | 108 | 3 | GO:0048143 | |
| GeneOntologyBiologicalProcess | axon regeneration | 4.73e-04 | 69 | 108 | 4 | GO:0031103 | |
| GeneOntologyCellularComponent | apical part of cell | VLDLR FN1 FOLR1 CD55 DLL1 LDLR ADCY8 CRB1 EGFR JAG1 LRP1 LRP2 UMOD NOTCH1 | 3.43e-06 | 592 | 112 | 14 | GO:0045177 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 5.70e-05 | 320 | 112 | 9 | GO:0016323 | |
| GeneOntologyCellularComponent | apical plasma membrane | 6.19e-05 | 487 | 112 | 11 | GO:0016324 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 7.05e-05 | 80 | 112 | 5 | GO:0005905 | |
| GeneOntologyCellularComponent | cell surface | VLDLR FOLR1 MYO18A CD55 LDLR ITGB7 CD209 PTN EGFR CD163L1 LRP1 LRP2 UMOD FGG NOTCH1 NOTCH2 SORL1 | 8.60e-05 | 1111 | 112 | 17 | GO:0009986 |
| GeneOntologyCellularComponent | protein phosphatase type 2A complex | 1.15e-04 | 18 | 112 | 3 | GO:0000159 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.23e-04 | 354 | 112 | 9 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 2.01e-04 | 378 | 112 | 9 | GO:0045178 | |
| GeneOntologyCellularComponent | endocytic vesicle | 2.26e-04 | 384 | 112 | 9 | GO:0030139 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 2.91e-04 | 237 | 112 | 7 | GO:0030136 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 4.62e-04 | 67 | 112 | 4 | GO:0031093 | |
| GeneOntologyCellularComponent | vesicle membrane | NPC1 CYBB SPIRE2 FOLR1 CD55 FNDC3A ACTN1 SYT10 LDLR ADCY8 SCARF1 SLCO4C1 EGFR LRP1 LRP2 NOTCH1 SORL1 | 6.77e-04 | 1325 | 112 | 17 | GO:0012506 |
| GeneOntologyCellularComponent | fibrinogen complex | 7.80e-04 | 8 | 112 | 2 | GO:0005577 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 9.94e-04 | 212 | 112 | 6 | GO:0030666 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.29e-03 | 223 | 112 | 6 | GO:0098862 | |
| GeneOntologyCellularComponent | platelet alpha granule | 1.58e-03 | 93 | 112 | 4 | GO:0031091 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | NPC1 CYBB SPIRE2 FOLR1 CD55 ACTN1 SYT10 LDLR ADCY8 SCARF1 SLCO4C1 EGFR LRP1 LRP2 NOTCH1 SORL1 | 1.61e-03 | 1307 | 112 | 16 | GO:0030659 |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 2.14e-03 | 101 | 112 | 4 | GO:0045334 | |
| GeneOntologyCellularComponent | secretory granule | CYBB FN1 GAS6 CD55 FNDC3A NCF2 ACTN1 SPATA1 SLCO4C1 LRP1 ZPBP2 FGG NOTCH1 | 3.03e-03 | 1014 | 112 | 13 | GO:0030141 |
| GeneOntologyCellularComponent | phosphatase complex | 3.21e-03 | 55 | 112 | 3 | GO:1903293 | |
| GeneOntologyCellularComponent | protein serine/threonine phosphatase complex | 3.21e-03 | 55 | 112 | 3 | GO:0008287 | |
| GeneOntologyCellularComponent | coated vesicle | 3.28e-03 | 360 | 112 | 7 | GO:0030135 | |
| HumanPheno | Abnormal phagocytosis | 4.44e-06 | 5 | 40 | 3 | HP:0010977 | |
| HumanPheno | Absence of bactericidal oxidative respiratory burst in phagocytes | 4.44e-06 | 5 | 40 | 3 | HP:0002723 | |
| MousePheno | abnormal somatic sensory system morphology | NPC1 VLDLR FOLR1 GNPTAB LAMA2 DLL1 NSUN2 LDLR CRB1 LOXHD1 EGFR JAG1 FST MEGF11 NOTCH1 | 2.19e-05 | 702 | 86 | 15 | MP:0000959 |
| MousePheno | decreased circulating transferrin level | 2.62e-05 | 10 | 86 | 3 | MP:0011894 | |
| Domain | EGF-like_CS | VLDLR FN1 ADAM23 SCARF2 GAS6 NOTCH2NLA LAMA2 ADAM11 DLL1 NOTCH2NLC LRP1B LDLR ITGB7 CRB1 SCARF1 NELL1 MEGF9 JAG1 LRP1 LRP2 UMOD MEGF11 NOTCH1 NOTCH2 SORL1 | 2.18e-23 | 261 | 111 | 25 | IPR013032 |
| Domain | EGF | VLDLR BRINP3 ADAM23 SCARF2 GAS6 NOTCH2NLA LAMA2 ADAM11 DLL1 NOTCH2NLC LRP1B LDLR CRB1 SCARF1 NELL1 MEGF9 JAG1 LRP1 LRP2 UMOD MEGF11 NOTCH1 NOTCH2 SORL1 | 3.88e-23 | 235 | 111 | 24 | SM00181 |
| Domain | EGF_1 | VLDLR FN1 ADAM23 SCARF2 GAS6 NOTCH2NLA LAMA2 ADAM11 DLL1 NOTCH2NLC LRP1B LDLR ITGB7 CRB1 SCARF1 NELL1 MEGF9 JAG1 LRP1 LRP2 UMOD MEGF11 NOTCH1 NOTCH2 | 2.78e-22 | 255 | 111 | 24 | PS00022 |
| Domain | EGF_2 | VLDLR ADAM23 SCARF2 GAS6 NOTCH2NLA LAMA2 ADAM11 DLL1 NOTCH2NLC LRP1B LDLR ITGB7 CRB1 SCARF1 NELL1 MEGF9 JAG1 LRP1 LRP2 UMOD MEGF11 NOTCH1 NOTCH2 SORL1 | 6.98e-22 | 265 | 111 | 24 | PS01186 |
| Domain | EGF-like_dom | VLDLR ADAM23 SCARF2 GAS6 NOTCH2NLA LAMA2 ADAM11 DLL1 NOTCH2NLC LRP1B LDLR CRB1 SCARF1 NELL1 MEGF9 JAG1 LRP1 LRP2 UMOD MEGF11 NOTCH1 NOTCH2 SORL1 | 3.48e-21 | 249 | 111 | 23 | IPR000742 |
| Domain | EGF_3 | VLDLR ADAM23 SCARF2 GAS6 NOTCH2NLA ADAM11 DLL1 NOTCH2NLC LRP1B LDLR CRB1 SCARF1 NELL1 JAG1 LRP1 LRP2 UMOD MEGF11 NOTCH1 NOTCH2 SORL1 | 4.32e-19 | 235 | 111 | 21 | PS50026 |
| Domain | EGF_Ca-bd_CS | VLDLR GAS6 NOTCH2NLA DLL1 NOTCH2NLC LRP1B LDLR CRB1 NELL1 JAG1 LRP1 LRP2 UMOD NOTCH1 NOTCH2 | 1.58e-17 | 97 | 111 | 15 | IPR018097 |
| Domain | EGF_CA | VLDLR GAS6 NOTCH2NLA DLL1 NOTCH2NLC LRP1B LDLR CRB1 NELL1 JAG1 LRP1 LRP2 UMOD NOTCH1 NOTCH2 | 2.18e-17 | 99 | 111 | 15 | PS01187 |
| Domain | ASX_HYDROXYL | VLDLR GAS6 NOTCH2NLA DLL1 NOTCH2NLC LRP1B LDLR CRB1 NELL1 JAG1 LRP1 LRP2 UMOD NOTCH1 NOTCH2 | 2.56e-17 | 100 | 111 | 15 | PS00010 |
| Domain | Growth_fac_rcpt_ | VLDLR BRINP3 SCARF2 GAS6 DLL1 LRP1B LDLR CRB1 SCARF1 NELL1 EGFR JAG1 LRP1 LRP2 UMOD NOTCH1 NOTCH2 | 4.48e-17 | 156 | 111 | 17 | IPR009030 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | VLDLR GAS6 NOTCH2NLA DLL1 NOTCH2NLC LRP1B LDLR CRB1 NELL1 JAG1 LRP1 LRP2 UMOD NOTCH1 NOTCH2 | 6.36e-17 | 106 | 111 | 15 | IPR000152 |
| Domain | EGF_CA | VLDLR GAS6 NOTCH2NLA DLL1 NOTCH2NLC LRP1B LDLR CRB1 NELL1 JAG1 LRP1 LRP2 UMOD NOTCH1 NOTCH2 | 5.59e-16 | 122 | 111 | 15 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | VLDLR GAS6 NOTCH2NLA DLL1 NOTCH2NLC LRP1B LDLR CRB1 NELL1 JAG1 LRP1 LRP2 UMOD NOTCH1 NOTCH2 | 7.17e-16 | 124 | 111 | 15 | IPR001881 |
| Domain | EGF_CA | VLDLR GAS6 NOTCH2NLA NOTCH2NLC LRP1B LDLR NELL1 JAG1 LRP1 LRP2 UMOD NOTCH1 NOTCH2 | 3.40e-15 | 86 | 111 | 13 | PF07645 |
| Domain | EGF_extracell | ADAM23 SCARF2 ADAM11 LRP1B ITGB7 SCARF1 NELL1 JAG1 LRP2 MEGF11 NOTCH1 | 5.29e-14 | 60 | 111 | 11 | IPR013111 |
| Domain | EGF_2 | ADAM23 SCARF2 ADAM11 LRP1B ITGB7 SCARF1 NELL1 JAG1 LRP2 MEGF11 NOTCH1 | 5.29e-14 | 60 | 111 | 11 | PF07974 |
| Domain | EGF | VLDLR GAS6 NOTCH2NLA DLL1 NOTCH2NLC LRP1B CRB1 JAG1 LRP1 LRP2 UMOD NOTCH1 NOTCH2 | 5.48e-13 | 126 | 111 | 13 | PF00008 |
| Domain | Ldl_recept_b | 1.11e-10 | 14 | 111 | 6 | PF00058 | |
| Domain | LDLRB | 1.11e-10 | 14 | 111 | 6 | PS51120 | |
| Domain | LY | 1.84e-10 | 15 | 111 | 6 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.84e-10 | 15 | 111 | 6 | IPR000033 | |
| Domain | hEGF | 2.31e-10 | 28 | 111 | 7 | PF12661 | |
| Domain | LDLR_class-A_CS | 3.43e-09 | 40 | 111 | 7 | IPR023415 | |
| Domain | Ldl_recept_a | 8.15e-09 | 45 | 111 | 7 | PF00057 | |
| Domain | - | 9.56e-09 | 46 | 111 | 7 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.30e-08 | 48 | 111 | 7 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 1.51e-08 | 49 | 111 | 7 | IPR002172 | |
| Domain | LDLa | 1.51e-08 | 49 | 111 | 7 | SM00192 | |
| Domain | LDLRA_2 | 1.51e-08 | 49 | 111 | 7 | PS50068 | |
| Domain | Notch_dom | 4.08e-08 | 7 | 111 | 4 | IPR000800 | |
| Domain | Notch | 4.08e-08 | 7 | 111 | 4 | PF00066 | |
| Domain | NL | 4.08e-08 | 7 | 111 | 4 | SM00004 | |
| Domain | - | 1.07e-07 | 39 | 111 | 6 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.97e-07 | 46 | 111 | 6 | IPR011042 | |
| Domain | PP2A_PR55_CS | 8.14e-07 | 4 | 111 | 3 | IPR018067 | |
| Domain | PP2A_PR55 | 8.14e-07 | 4 | 111 | 3 | IPR000009 | |
| Domain | PR55_2 | 8.14e-07 | 4 | 111 | 3 | PS01025 | |
| Domain | PR55_1 | 8.14e-07 | 4 | 111 | 3 | PS01024 | |
| Domain | Laminin_EGF | 1.91e-06 | 35 | 111 | 5 | PF00053 | |
| Domain | LNR | 2.03e-06 | 5 | 111 | 3 | PS50258 | |
| Domain | Laminin_EGF | 2.91e-06 | 38 | 111 | 5 | IPR002049 | |
| Domain | cEGF | 1.60e-05 | 26 | 111 | 4 | PF12662 | |
| Domain | cEGF | 1.60e-05 | 26 | 111 | 4 | IPR026823 | |
| Domain | DUF5050 | 3.50e-05 | 2 | 111 | 2 | IPR032485 | |
| Domain | DUF5050 | 3.50e-05 | 2 | 111 | 2 | PF16472 | |
| Domain | EGF_Lam | 5.37e-05 | 35 | 111 | 4 | SM00180 | |
| Domain | Laminin_G_2 | 9.16e-05 | 40 | 111 | 4 | PF02210 | |
| Domain | DUF3454 | 1.05e-04 | 3 | 111 | 2 | PF11936 | |
| Domain | DUF3454_notch | 1.05e-04 | 3 | 111 | 2 | IPR024600 | |
| Domain | DUF3454 | 1.05e-04 | 3 | 111 | 2 | SM01334 | |
| Domain | LamG | 1.34e-04 | 44 | 111 | 4 | SM00282 | |
| Domain | Notch | 2.08e-04 | 4 | 111 | 2 | IPR008297 | |
| Domain | NODP | 2.08e-04 | 4 | 111 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 2.08e-04 | 4 | 111 | 2 | IPR011656 | |
| Domain | DSL | 2.08e-04 | 4 | 111 | 2 | PF01414 | |
| Domain | Notch_NOD_dom | 2.08e-04 | 4 | 111 | 2 | IPR010660 | |
| Domain | NOD | 2.08e-04 | 4 | 111 | 2 | PF06816 | |
| Domain | DSL | 2.08e-04 | 4 | 111 | 2 | SM00051 | |
| Domain | NOD | 2.08e-04 | 4 | 111 | 2 | SM01338 | |
| Domain | NODP | 2.08e-04 | 4 | 111 | 2 | SM01339 | |
| Domain | - | 2.56e-04 | 95 | 111 | 5 | 2.60.120.200 | |
| Domain | ConA-like_dom | 3.35e-04 | 219 | 111 | 7 | IPR013320 | |
| Domain | DSL | 3.46e-04 | 5 | 111 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 3.46e-04 | 5 | 111 | 2 | IPR011651 | |
| Domain | MNNL | 3.46e-04 | 5 | 111 | 2 | PF07657 | |
| Domain | DSL | 3.46e-04 | 5 | 111 | 2 | IPR001774 | |
| Domain | Laminin_G | 3.92e-04 | 58 | 111 | 4 | IPR001791 | |
| Domain | BBOX | 7.59e-04 | 69 | 111 | 4 | SM00336 | |
| Domain | - | 8.45e-04 | 71 | 111 | 4 | 4.10.45.10 | |
| Domain | PHD | 1.04e-03 | 75 | 111 | 4 | PF00628 | |
| Domain | Znf_PHD-finger | 1.26e-03 | 79 | 111 | 4 | IPR019787 | |
| Domain | Kazal_2 | 1.26e-03 | 36 | 111 | 3 | PF07648 | |
| Domain | ZF_BBOX | 1.32e-03 | 80 | 111 | 4 | PS50119 | |
| Domain | BROMODOMAIN_1 | 1.37e-03 | 37 | 111 | 3 | PS00633 | |
| Domain | Znf_B-box | 1.38e-03 | 81 | 111 | 4 | IPR000315 | |
| Domain | Bromodomain | 1.48e-03 | 38 | 111 | 3 | PF00439 | |
| Domain | LAM_G_DOMAIN | 1.48e-03 | 38 | 111 | 3 | PS50025 | |
| Domain | BROMODOMAIN_2 | 1.85e-03 | 41 | 111 | 3 | PS50014 | |
| Domain | Znf_FYVE_PHD | 1.85e-03 | 147 | 111 | 5 | IPR011011 | |
| Domain | Laminin_G_1 | 1.86e-03 | 11 | 111 | 2 | PF00054 | |
| Domain | PHD | 1.96e-03 | 89 | 111 | 4 | SM00249 | |
| Domain | Bromodomain | 1.98e-03 | 42 | 111 | 3 | IPR001487 | |
| Domain | BROMO | 1.98e-03 | 42 | 111 | 3 | SM00297 | |
| Domain | - | 1.98e-03 | 42 | 111 | 3 | 1.20.920.10 | |
| Domain | Znf_PHD | 2.12e-03 | 91 | 111 | 4 | IPR001965 | |
| Domain | EGF_dom | 2.22e-03 | 12 | 111 | 2 | IPR024731 | |
| Domain | calpain_III | 2.22e-03 | 12 | 111 | 2 | SM00720 | |
| Domain | C2_III | 2.22e-03 | 12 | 111 | 2 | IPR033883 | |
| Domain | Quinoprot_gluc/sorb_DH | 2.22e-03 | 12 | 111 | 2 | IPR011041 | |
| Domain | EGF_3 | 2.22e-03 | 12 | 111 | 2 | PF12947 | |
| Domain | Calpain_III | 2.22e-03 | 12 | 111 | 2 | IPR022683 | |
| Domain | ZF_PHD_2 | 2.48e-03 | 95 | 111 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 2.58e-03 | 96 | 111 | 4 | PS01359 | |
| Domain | Calpain_III | 2.62e-03 | 13 | 111 | 2 | PF01067 | |
| Domain | Calpain_domain_III | 2.62e-03 | 13 | 111 | 2 | IPR022682 | |
| Domain | Ras_G-nucl-exch_fac_CS | 3.04e-03 | 14 | 111 | 2 | IPR019804 | |
| Domain | Calpain_cysteine_protease | 3.04e-03 | 14 | 111 | 2 | IPR022684 | |
| Domain | KAZAL_2 | 3.27e-03 | 50 | 111 | 3 | PS51465 | |
| Domain | Kazal_dom | 3.46e-03 | 51 | 111 | 3 | IPR002350 | |
| Domain | Bbox_C | 3.49e-03 | 15 | 111 | 2 | IPR003649 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 5.32e-09 | 24 | 86 | 6 | M11190 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 8.85e-07 | 13 | 86 | 4 | M47423 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 5.35e-06 | 42 | 86 | 5 | M174 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 7.54e-06 | 7 | 86 | 3 | M27199 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | NPC1 ACSL6 VLDLR SCARF2 LRP1B LDLR CD209 CD163L1 LRP1 LRP2 SORL1 | 1.93e-05 | 381 | 86 | 11 | M48063 |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 2.04e-05 | 27 | 86 | 4 | M39545 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 3.49e-05 | 11 | 86 | 3 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 3.49e-05 | 11 | 86 | 3 | M47432 | |
| Pathway | BIOCARTA_HES_PATHWAY | 4.63e-05 | 12 | 86 | 3 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 4.63e-05 | 12 | 86 | 3 | M22042 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 4.63e-05 | 12 | 86 | 3 | M47532 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 5.61e-05 | 161 | 86 | 7 | M39770 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 6.00e-05 | 13 | 86 | 3 | M47594 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 6.00e-05 | 13 | 86 | 3 | M42551 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 9.02e-05 | 39 | 86 | 4 | MM14604 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 9.46e-05 | 15 | 86 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 9.46e-05 | 15 | 86 | 3 | M47375 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 9.46e-05 | 15 | 86 | 3 | M1262 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 9.46e-05 | 15 | 86 | 3 | MM14959 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.46e-05 | 15 | 86 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 9.46e-05 | 15 | 86 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.46e-05 | 15 | 86 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.46e-05 | 15 | 86 | 3 | M47497 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 9.46e-05 | 15 | 86 | 3 | M27202 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.46e-05 | 15 | 86 | 3 | M47531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.16e-04 | 16 | 86 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 1.16e-04 | 16 | 86 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.16e-04 | 16 | 86 | 3 | M47424 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 1.35e-04 | 129 | 86 | 6 | M39693 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.40e-04 | 17 | 86 | 3 | M39389 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.42e-04 | 82 | 86 | 5 | MM15922 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.59e-04 | 45 | 86 | 4 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.73e-04 | 46 | 86 | 4 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.89e-04 | 47 | 86 | 4 | M7946 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.98e-04 | 19 | 86 | 3 | MM15594 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 1.98e-04 | 19 | 86 | 3 | M47525 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.11e-04 | 199 | 86 | 7 | M7253 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.18e-04 | 339 | 86 | 9 | M39736 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 2.22e-04 | 49 | 86 | 4 | M618 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 3.10e-04 | 22 | 86 | 3 | M27210 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 3.10e-04 | 22 | 86 | 3 | M47919 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 3.53e-04 | 154 | 86 | 6 | M39739 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 3.64e-04 | 5 | 86 | 2 | M27411 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 3.99e-04 | 57 | 86 | 4 | M48326 | |
| Pathway | PID_NOTCH_PATHWAY | 4.55e-04 | 59 | 86 | 4 | M17 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 4.58e-04 | 25 | 86 | 3 | M27879 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 5.04e-04 | 302 | 86 | 8 | M39719 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 5.11e-04 | 464 | 86 | 10 | M27547 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 5.17e-04 | 61 | 86 | 4 | M39540 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 5.43e-04 | 6 | 86 | 2 | MM1584 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 5.43e-04 | 6 | 86 | 2 | M22074 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 5.43e-04 | 6 | 86 | 2 | M27068 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 5.77e-04 | 27 | 86 | 3 | M760 | |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 6.43e-04 | 28 | 86 | 3 | M39572 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 6.43e-04 | 28 | 86 | 3 | MM14958 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 7.57e-04 | 7 | 86 | 2 | MM14879 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 7.90e-04 | 30 | 86 | 3 | M47724 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 8.25e-04 | 69 | 86 | 4 | M48052 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 8.32e-04 | 326 | 86 | 8 | MM15917 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 8.71e-04 | 31 | 86 | 3 | M592 | |
| Pathway | WP_FOCAL_ADHESION | 9.82e-04 | 187 | 86 | 6 | MM15913 | |
| Pathway | REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS | 1.01e-03 | 8 | 86 | 2 | M27376 | |
| Pathway | REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS | 1.01e-03 | 8 | 86 | 2 | MM15124 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES | 1.01e-03 | 8 | 86 | 2 | M26926 | |
| Pathway | WP_CANCER_PATHWAYS | 1.01e-03 | 507 | 86 | 10 | M48302 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 1.05e-03 | 33 | 86 | 3 | M604 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 1.14e-03 | 34 | 86 | 3 | MM15566 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 1.29e-03 | 9 | 86 | 2 | M27156 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 1.29e-03 | 9 | 86 | 2 | M47866 | |
| Pathway | WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS | 1.29e-03 | 9 | 86 | 2 | M39869 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES | 1.29e-03 | 9 | 86 | 2 | MM14524 | |
| Pathway | WP_FOCAL_ADHESION | 1.35e-03 | 199 | 86 | 6 | M39402 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 1.47e-03 | 37 | 86 | 3 | M27847 | |
| Pathway | WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE | 1.47e-03 | 37 | 86 | 3 | M45513 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE | 1.59e-03 | 38 | 86 | 3 | M27536 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 1.59e-03 | 38 | 86 | 3 | MM15456 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELLING_SOMITOGENESIS | 1.60e-03 | 10 | 86 | 2 | MM15839 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS | 1.60e-03 | 10 | 86 | 2 | M47930 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 1.71e-03 | 39 | 86 | 3 | M10735 | |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 1.72e-03 | 84 | 86 | 4 | M39839 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 1.91e-03 | 213 | 86 | 6 | M18306 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.95e-03 | 11 | 86 | 2 | MM15578 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.95e-03 | 11 | 86 | 2 | M47865 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS | 1.95e-03 | 11 | 86 | 2 | M39647 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3 | 1.96e-03 | 87 | 86 | 4 | M39465 | |
| Pathway | KEGG_GAP_JUNCTION | 2.21e-03 | 90 | 86 | 4 | M4013 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 2.22e-03 | 150 | 86 | 5 | M39520 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 2.33e-03 | 12 | 86 | 2 | M47533 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 2.36e-03 | 152 | 86 | 5 | MM15834 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.36e-03 | 300 | 86 | 7 | M610 | |
| Pathway | REACTOME_NEPHRON_DEVELOPMENT | 2.75e-03 | 13 | 86 | 2 | M48245 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 2.75e-03 | 13 | 86 | 2 | MM14701 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1 | 2.75e-03 | 13 | 86 | 2 | M6322 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 2.75e-03 | 13 | 86 | 2 | M47534 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 2.75e-03 | 46 | 86 | 3 | M39828 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 3.11e-03 | 48 | 86 | 3 | M27642 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 3.19e-03 | 14 | 86 | 2 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 3.19e-03 | 14 | 86 | 2 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 3.19e-03 | 14 | 86 | 2 | M47366 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 3.19e-03 | 14 | 86 | 2 | MM15277 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 4.38e-11 | 101 | 112 | 9 | 23382219 | |
| Pubmed | Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes. | 1.02e-10 | 4 | 112 | 4 | 22390640 | |
| Pubmed | Evolution of Human Brain Size-Associated NOTCH2NL Genes Proceeds toward Reduced Protein Levels. | 1.02e-10 | 4 | 112 | 4 | 32330268 | |
| Pubmed | 5.08e-10 | 5 | 112 | 4 | 11713346 | ||
| Pubmed | 5.08e-10 | 5 | 112 | 4 | 18685438 | ||
| Pubmed | Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis. | 5.08e-10 | 5 | 112 | 4 | 29856954 | |
| Pubmed | Human-Specific NOTCH2NL Genes Expand Cortical Neurogenesis through Delta/Notch Regulation. | 5.08e-10 | 5 | 112 | 4 | 29856955 | |
| Pubmed | 1.34e-09 | 16 | 112 | 5 | 32161758 | ||
| Pubmed | 1.52e-09 | 6 | 112 | 4 | 10958687 | ||
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 1.52e-09 | 6 | 112 | 4 | 19603167 | |
| Pubmed | 1.52e-09 | 6 | 112 | 4 | 31071093 | ||
| Pubmed | 3.54e-09 | 7 | 112 | 4 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 3.54e-09 | 7 | 112 | 4 | 12846471 | |
| Pubmed | Differentiation of CD11c+ CX3CR1+ cells in the small intestine requires Notch signaling. | 3.54e-09 | 7 | 112 | 4 | 24711412 | |
| Pubmed | 3.54e-09 | 7 | 112 | 4 | 12169628 | ||
| Pubmed | NPC1 VLDLR FN1 ADAM23 GNPTAB ACTN1 ZNF227 NSUN2 LRP1B GFPT1 XAB2 TRIM33 NELL1 GDAP1L1 UBE2O MEGF9 LRP1 LRP2 SOS1 SOS2 | 5.00e-09 | 1285 | 112 | 20 | 35914814 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 6.18e-09 | 21 | 112 | 5 | 21337463 | |
| Pubmed | Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. | 7.06e-09 | 8 | 112 | 4 | 15465493 | |
| Pubmed | 7.06e-09 | 8 | 112 | 4 | 9858718 | ||
| Pubmed | 7.06e-09 | 8 | 112 | 4 | 11044610 | ||
| Pubmed | 1.27e-08 | 9 | 112 | 4 | 11118901 | ||
| Pubmed | 1.27e-08 | 9 | 112 | 4 | 16245338 | ||
| Pubmed | 1.27e-08 | 9 | 112 | 4 | 20005821 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 2.11e-08 | 10 | 112 | 4 | 23665443 | |
| Pubmed | 2.11e-08 | 10 | 112 | 4 | 24015274 | ||
| Pubmed | Both Notch1 and its ligands in B cells promote antibody production. | 3.25e-08 | 3 | 112 | 3 | 28863329 | |
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 22080880 | ||
| Pubmed | Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. | 3.25e-08 | 3 | 112 | 3 | 14726396 | |
| Pubmed | Notch signaling confers antigen-presenting cell functions on mast cells. | 3.25e-08 | 3 | 112 | 3 | 19130928 | |
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 15976178 | ||
| Pubmed | Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia. | 3.25e-08 | 3 | 112 | 3 | 20812035 | |
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 18367731 | ||
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 15781650 | ||
| Pubmed | 3.30e-08 | 11 | 112 | 4 | 10878608 | ||
| Pubmed | 3.30e-08 | 11 | 112 | 4 | 12866128 | ||
| Pubmed | 3.30e-08 | 11 | 112 | 4 | 24639464 | ||
| Pubmed | Defects in somite formation in lunatic fringe-deficient mice. | 3.30e-08 | 11 | 112 | 4 | 9690472 | |
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 3.30e-08 | 11 | 112 | 4 | 9187150 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 3.30e-08 | 11 | 112 | 4 | 15499562 | |
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 4.23e-08 | 30 | 112 | 5 | 24552588 | |
| Pubmed | 4.94e-08 | 12 | 112 | 4 | 14732396 | ||
| Pubmed | 4.94e-08 | 12 | 112 | 4 | 17572911 | ||
| Pubmed | 4.94e-08 | 12 | 112 | 4 | 15465494 | ||
| Pubmed | Node and midline defects are associated with left-right development in Delta1 mutant embryos. | 7.12e-08 | 13 | 112 | 4 | 12441287 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 7.12e-08 | 13 | 112 | 4 | 11578869 | |
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 7.12e-08 | 13 | 112 | 4 | 31202705 | |
| Pubmed | 9.95e-08 | 14 | 112 | 4 | 15082773 | ||
| Pubmed | 9.95e-08 | 14 | 112 | 4 | 23806616 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 9.95e-08 | 14 | 112 | 4 | 17389516 | |
| Pubmed | 9.95e-08 | 14 | 112 | 4 | 14757642 | ||
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 15863833 | ||
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 24398584 | ||
| Pubmed | Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2. | 1.30e-07 | 4 | 112 | 3 | 32820046 | |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 29561261 | ||
| Pubmed | Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming. | 1.30e-07 | 4 | 112 | 3 | 30226866 | |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 10551863 | ||
| Pubmed | Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. | 1.30e-07 | 4 | 112 | 3 | 9244302 | |
| Pubmed | Developmental regulation of LR11 expression in murine brain. | 1.30e-07 | 4 | 112 | 3 | 9726247 | |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 9858728 | ||
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 15840700 | ||
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 9315665 | ||
| Pubmed | No evidence for a functional role of bi-directional Notch signaling during angiogenesis. | 1.30e-07 | 4 | 112 | 3 | 23300864 | |
| Pubmed | Notch controls the survival of memory CD4+ T cells by regulating glucose uptake. | 1.30e-07 | 4 | 112 | 3 | 25501905 | |
| Pubmed | 1.35e-07 | 15 | 112 | 4 | 12971992 | ||
| Pubmed | 1.35e-07 | 15 | 112 | 4 | 25725069 | ||
| Pubmed | COUP-TFI controls Notch regulation of hair cell and support cell differentiation. | 1.35e-07 | 15 | 112 | 4 | 16914494 | |
| Pubmed | Lunatic fringe, FGF, and BMP regulate the Notch pathway during epithelial morphogenesis of teeth. | 1.35e-07 | 15 | 112 | 4 | 12167404 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.57e-07 | 184 | 112 | 8 | 32908313 | |
| Pubmed | 1.80e-07 | 16 | 112 | 4 | 17273555 | ||
| Pubmed | The Cellular Prion Protein Controls Notch Signaling in Neural Stem/Progenitor Cells. | 1.80e-07 | 16 | 112 | 4 | 27641601 | |
| Pubmed | Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. | 1.80e-07 | 16 | 112 | 4 | 17229764 | |
| Pubmed | 1.80e-07 | 16 | 112 | 4 | 10842072 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 1.80e-07 | 16 | 112 | 4 | 12617809 | |
| Pubmed | 1.90e-07 | 40 | 112 | 5 | 23362348 | ||
| Pubmed | 2.35e-07 | 17 | 112 | 4 | 18694942 | ||
| Pubmed | 2.35e-07 | 17 | 112 | 4 | 10476967 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 2.35e-07 | 17 | 112 | 4 | 15821257 | |
| Pubmed | 3.01e-07 | 18 | 112 | 4 | 10827173 | ||
| Pubmed | 3.01e-07 | 18 | 112 | 4 | 15689374 | ||
| Pubmed | 3.01e-07 | 18 | 112 | 4 | 18093989 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 9030684 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 22445366 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 12175503 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 19047013 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 19682396 | ||
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 3.24e-07 | 5 | 112 | 3 | 11006133 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 11346656 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 30700132 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 30181175 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 12746448 | ||
| Pubmed | Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo. | 3.24e-07 | 5 | 112 | 3 | 18992221 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 27118257 | ||
| Pubmed | Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. | 3.24e-07 | 5 | 112 | 3 | 23959870 | |
| Pubmed | Immunohistochemical expression of Notch signaling in the lining epithelium of periapical cysts. | 3.24e-07 | 5 | 112 | 3 | 21238798 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 20554499 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 8013374 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 3.24e-07 | 5 | 112 | 3 | 15064243 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 15882997 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 35064244 | ||
| Pubmed | 3.80e-07 | 19 | 112 | 4 | 20335360 | ||
| Interaction | NTN5 interactions | 2.86e-09 | 24 | 110 | 6 | int:NTN5 | |
| Interaction | IGFL3 interactions | 7.58e-09 | 75 | 110 | 8 | int:IGFL3 | |
| Interaction | FOXD4L6 interactions | 8.46e-09 | 49 | 110 | 7 | int:FOXD4L6 | |
| Interaction | ZFP41 interactions | 2.51e-08 | 57 | 110 | 7 | int:ZFP41 | |
| Interaction | DAB1 interactions | 1.27e-07 | 107 | 110 | 8 | int:DAB1 | |
| Interaction | ZNF408 interactions | 1.31e-06 | 145 | 110 | 8 | int:ZNF408 | |
| Interaction | IER2 interactions | 1.68e-06 | 37 | 110 | 5 | int:IER2 | |
| Interaction | CLEC18A interactions | 1.89e-06 | 17 | 110 | 4 | int:CLEC18A | |
| Interaction | LGALS1 interactions | NPC1 FN1 GNPTAB LDLR MEGF9 EGFR JAG1 LRP2 NOTCH1 NOTCH2 SORL1 | 2.05e-06 | 332 | 110 | 11 | int:LGALS1 |
| Interaction | FBXO2 interactions | NPC1 FN1 ADAM23 GNPTAB GAS6 LRP1B EGFR JAG1 LRP2 NOTCH1 NOTCH2 SORL1 | 2.56e-06 | 411 | 110 | 12 | int:FBXO2 |
| Interaction | SERTAD4 interactions | 3.06e-06 | 19 | 110 | 4 | int:SERTAD4 | |
| Interaction | CCN6 interactions | 3.06e-06 | 19 | 110 | 4 | int:CCN6 | |
| Interaction | EGFL6 interactions | 4.68e-06 | 21 | 110 | 4 | int:EGFL6 | |
| Interaction | WNT3A interactions | 6.96e-06 | 49 | 110 | 5 | int:WNT3A | |
| Interaction | TIMP3 interactions | 9.89e-06 | 90 | 110 | 6 | int:TIMP3 | |
| Interaction | ZNF319 interactions | 1.34e-05 | 27 | 110 | 4 | int:ZNF319 | |
| Interaction | MFNG interactions | 1.34e-05 | 27 | 110 | 4 | int:MFNG | |
| Interaction | FEZF1 interactions | 1.56e-05 | 28 | 110 | 4 | int:FEZF1 | |
| Interaction | ZNF517 interactions | 1.80e-05 | 29 | 110 | 4 | int:ZNF517 | |
| Interaction | ANKRD36B interactions | 1.90e-05 | 60 | 110 | 5 | int:ANKRD36B | |
| Interaction | PABIR1 interactions | 2.36e-05 | 31 | 110 | 4 | int:PABIR1 | |
| Interaction | EDN3 interactions | 2.81e-05 | 108 | 110 | 6 | int:EDN3 | |
| Interaction | HBA1 interactions | 3.26e-05 | 67 | 110 | 5 | int:HBA1 | |
| Interaction | ZNF563 interactions | 3.36e-05 | 12 | 110 | 3 | int:ZNF563 | |
| Interaction | ZNF672 interactions | 3.36e-05 | 12 | 110 | 3 | int:ZNF672 | |
| Interaction | COL17A1 interactions | 3.43e-05 | 34 | 110 | 4 | int:COL17A1 | |
| Interaction | IER5 interactions | 4.35e-05 | 13 | 110 | 3 | int:IER5 | |
| Interaction | GREM2 interactions | 4.83e-05 | 37 | 110 | 4 | int:GREM2 | |
| Interaction | PRR19 interactions | 5.51e-05 | 14 | 110 | 3 | int:PRR19 | |
| Interaction | IGSF5 interactions | 5.51e-05 | 14 | 110 | 3 | int:IGSF5 | |
| Interaction | LRPAP1 interactions | 5.92e-05 | 180 | 110 | 7 | int:LRPAP1 | |
| Interaction | CCN2 interactions | 6.60e-05 | 40 | 110 | 4 | int:CCN2 | |
| Interaction | TAFA3 interactions | 6.80e-05 | 78 | 110 | 5 | int:TAFA3 | |
| Interaction | DEFB123 interactions | 8.41e-05 | 16 | 110 | 3 | int:DEFB123 | |
| Interaction | TFPI2 interactions | 8.80e-05 | 43 | 110 | 4 | int:TFPI2 | |
| Interaction | LRP1B interactions | 1.02e-04 | 85 | 110 | 5 | int:LRP1B | |
| Interaction | KDM5C interactions | 1.15e-04 | 139 | 110 | 6 | int:KDM5C | |
| Interaction | DAB2 interactions | 1.20e-04 | 140 | 110 | 6 | int:DAB2 | |
| Interaction | MDK interactions | 1.42e-04 | 91 | 110 | 5 | int:MDK | |
| Interaction | TAPBPL interactions | 1.44e-04 | 19 | 110 | 3 | int:TAPBPL | |
| Interaction | DKK2 interactions | 1.47e-04 | 49 | 110 | 4 | int:DKK2 | |
| Interaction | ZNF224 interactions | 1.69e-04 | 20 | 110 | 3 | int:ZNF224 | |
| Interaction | NPBWR2 interactions | 1.69e-04 | 20 | 110 | 3 | int:NPBWR2 | |
| Interaction | FGA interactions | 1.73e-04 | 95 | 110 | 5 | int:FGA | |
| Interaction | ZNF486 interactions | 1.76e-04 | 4 | 110 | 2 | int:ZNF486 | |
| Interaction | SMAD9 interactions | 1.94e-04 | 153 | 110 | 6 | int:SMAD9 | |
| Interaction | GARIN6 interactions | 1.96e-04 | 21 | 110 | 3 | int:GARIN6 | |
| Interaction | HBZ interactions | 2.15e-04 | 54 | 110 | 4 | int:HBZ | |
| Interaction | APOB interactions | 2.16e-04 | 156 | 110 | 6 | int:APOB | |
| Interaction | SIRPA interactions | 2.20e-04 | 100 | 110 | 5 | int:SIRPA | |
| Interaction | LINC01588 interactions | 2.26e-04 | 22 | 110 | 3 | int:LINC01588 | |
| Interaction | MXI1 interactions | 2.31e-04 | 55 | 110 | 4 | int:MXI1 | |
| Interaction | WNT2 interactions | 2.59e-04 | 23 | 110 | 3 | int:WNT2 | |
| Interaction | SEC61B interactions | VLDLR FN1 SCARF2 RPS8 FNDC3A GBA2 LRP1B UBE2O EGFR LRP2 POFUT2 NOTCH1 NOTCH2 | 2.67e-04 | 763 | 110 | 13 | int:SEC61B |
| Interaction | FGG interactions | 2.77e-04 | 105 | 110 | 5 | int:FGG | |
| Interaction | WDR25 interactions | 2.84e-04 | 58 | 110 | 4 | int:WDR25 | |
| Interaction | MAPK8IP1 interactions | 2.84e-04 | 58 | 110 | 4 | int:MAPK8IP1 | |
| Interaction | ADAM12 interactions | 2.84e-04 | 58 | 110 | 4 | int:ADAM12 | |
| Interaction | BTBD18 interactions | 2.92e-04 | 5 | 110 | 2 | int:BTBD18 | |
| Interaction | SCARF2 interactions | 2.95e-04 | 24 | 110 | 3 | int:SCARF2 | |
| Interaction | HBA2 interactions | 3.02e-04 | 107 | 110 | 5 | int:HBA2 | |
| Interaction | RPS28 interactions | 3.43e-04 | 316 | 110 | 8 | int:RPS28 | |
| Interaction | APOE interactions | 3.53e-04 | 171 | 110 | 6 | int:APOE | |
| Interaction | SLC23A1 interactions | 3.75e-04 | 26 | 110 | 3 | int:SLC23A1 | |
| Interaction | NOTCH3 interactions | 3.89e-04 | 113 | 110 | 5 | int:NOTCH3 | |
| Interaction | PLAT interactions | 3.91e-04 | 63 | 110 | 4 | int:PLAT | |
| Interaction | ZNF331 interactions | 3.91e-04 | 63 | 110 | 4 | int:ZNF331 | |
| Interaction | CLU interactions | 3.96e-04 | 245 | 110 | 7 | int:CLU | |
| Interaction | PID1 interactions | 4.21e-04 | 27 | 110 | 3 | int:PID1 | |
| Interaction | ADAMTS9 interactions | 4.37e-04 | 6 | 110 | 2 | int:ADAMTS9 | |
| Interaction | CDK5R1 interactions | 4.40e-04 | 65 | 110 | 4 | int:CDK5R1 | |
| Interaction | KLK10 interactions | 4.64e-04 | 180 | 110 | 6 | int:KLK10 | |
| Interaction | TAB1 interactions | 4.69e-04 | 252 | 110 | 7 | int:TAB1 | |
| Interaction | CDH16 interactions | 4.69e-04 | 28 | 110 | 3 | int:CDH16 | |
| Interaction | LDLR interactions | 4.70e-04 | 417 | 110 | 9 | int:LDLR | |
| Interaction | ACLY interactions | 5.05e-04 | 335 | 110 | 8 | int:ACLY | |
| GeneFamily | Low density lipoprotein receptors | 2.26e-09 | 13 | 83 | 5 | 634 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 6.69e-06 | 27 | 83 | 4 | 1253 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 4.08e-05 | 15 | 83 | 3 | 696 | |
| GeneFamily | PHD finger proteins | 7.82e-04 | 90 | 83 | 4 | 88 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 9.57e-04 | 95 | 83 | 4 | 59 | |
| GeneFamily | C2 domain containing|Calpains | 2.10e-03 | 15 | 83 | 2 | 975 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 5.38e-03 | 24 | 83 | 2 | 615 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF486 ZNF337 ZNF208 ZNF227 ZNF248 ZNF728 ZFHX3 ZNF454 ZNF345 | 5.58e-03 | 718 | 83 | 9 | 28 |
| GeneFamily | NLR family | 5.83e-03 | 25 | 83 | 2 | 666 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 6.78e-03 | 27 | 83 | 2 | 47 | |
| GeneFamily | WD repeat domain containing | 7.13e-03 | 262 | 83 | 5 | 362 | |
| GeneFamily | Keratins, type I | 7.28e-03 | 28 | 83 | 2 | 608 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 5.14e-07 | 16 | 110 | 4 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 5.14e-07 | 16 | 110 | 4 | M2207 | |
| Coexpression | NABA_MATRISOME | BRINP3 FN1 SPOCK1 SFTPD ADAM23 GAS6 LAMA2 ADAM11 CD209 PTN NELL1 MEGF9 SEMA3B PAPPA FGG FST MEGF11 | 1.03e-06 | 1008 | 110 | 17 | MM17056 |
| Coexpression | NABA_MATRISOME | BRINP3 FN1 SPOCK1 SFTPD ADAM23 GAS6 LAMA2 ADAM11 CD209 PTN NELL1 MEGF9 SEMA3B PAPPA FGG FST MEGF11 | 1.31e-06 | 1026 | 110 | 17 | M5889 |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 3.97e-06 | 8 | 110 | 3 | M9884 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 9.64e-06 | 32 | 110 | 4 | M5903 | |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP | 1.38e-05 | 340 | 110 | 9 | M2012 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.48e-05 | 261 | 110 | 8 | M1834 | |
| Coexpression | HASINA_NOL7_TARGETS_DN | 1.99e-05 | 13 | 110 | 3 | M596 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_UP | 2.22e-05 | 200 | 110 | 7 | M3927 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | ACSL6 BRINP3 SPOCK1 ADAM23 GNPTAB LRP1B ZNF248 NELL1 PPP2R2C EML5 SCN9A ZFHX3 | 4.03e-05 | 703 | 110 | 12 | M39070 |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | CYBB SPIRE2 NOTCH2NLA LDLRAD3 PTN BAZ2A LRP1 ZFHX3 FGG NOTCH2 TBCD SOS2 | 7.12e-05 | 746 | 110 | 12 | M40863 |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN | 9.12e-05 | 250 | 110 | 7 | M13333 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | 1.20e-04 | 450 | 110 | 9 | M39072 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_SCHWANN_CELLS | 1.32e-04 | 116 | 110 | 5 | M40251 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT | 1.36e-04 | 24 | 110 | 3 | M38986 | |
| Coexpression | ZHANG_GATA6_TARGETS_DN | 1.45e-04 | 63 | 110 | 4 | M1778 | |
| Coexpression | ZHANG_GATA6_TARGETS_DN | 1.63e-04 | 65 | 110 | 4 | MM1226 | |
| Coexpression | AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP | 1.94e-04 | 126 | 110 | 5 | M2309 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN | 1.98e-04 | 199 | 110 | 6 | M5240 | |
| Coexpression | GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP | 1.98e-04 | 199 | 110 | 6 | M7210 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP | 2.03e-04 | 200 | 110 | 6 | M8090 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_UP | 2.03e-04 | 200 | 110 | 6 | M4948 | |
| Coexpression | GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN | 2.03e-04 | 200 | 110 | 6 | M4971 | |
| Coexpression | COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN | 2.18e-04 | 28 | 110 | 3 | M14859 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ACSL6 SPOCK1 ADAM23 GNPTAB LRP1B ZNF248 NELL1 PPP2R2B PPP2R2C GDAP1L1 MEGF9 SCN9A PAPPA ZFHX3 | 2.20e-04 | 1106 | 110 | 14 | M39071 |
| Coexpression | DESCARTES_FETAL_ADRENAL_SCHWANN_CELLS | 2.24e-04 | 130 | 110 | 5 | M40147 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-09 | 195 | 112 | 9 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 3.22e-08 | 193 | 112 | 8 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.49e-08 | 195 | 112 | 8 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-08 | 196 | 112 | 8 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-08 | 196 | 112 | 8 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.77e-08 | 197 | 112 | 8 | e239caae24f40564a24ad909754f5436f767ccdb | |
| ToppCell | COVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 3.93e-08 | 198 | 112 | 8 | 30ada3de865b6fb2b14196a1cbfd4740c6a57ce3 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.08e-08 | 199 | 112 | 8 | fb63885273d906a85fef178d859d20a311eb8a72 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.08e-08 | 199 | 112 | 8 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Sigmoid / Region, Cell class and subclass | 4.24e-08 | 200 | 112 | 8 | 9ee3a799de7bade1bfe94b6827461633f02bc1dc | |
| ToppCell | Sigmoid-(6)_Macrophage-(60)_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 4.24e-08 | 200 | 112 | 8 | ad84a83a5a1893f7b053d39eddeca851463a8ff0 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.24e-08 | 200 | 112 | 8 | 808571d74bb5c4d765ff13fc9393f88020d4e90d | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-07 | 153 | 112 | 7 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-07 | 160 | 112 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-07 | 160 | 112 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-07 | 180 | 112 | 7 | d9c9399df3e2d9f23dbbfffb6cbe8404bf01e2b7 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-07 | 180 | 112 | 7 | dad458398683ff80a6e207bdc08e257d1bb757d6 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.71e-07 | 180 | 112 | 7 | 38490017dd590e3fcfa7e88d8d15235d55f90cf1 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-07 | 182 | 112 | 7 | 812ff2a50a510b18d865e89465dba1754a08ef61 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.80e-07 | 187 | 112 | 7 | 8e8f1f2a78ac5f13a414fd448af7d7ff1ea86f0f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.54e-07 | 191 | 112 | 7 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.54e-07 | 191 | 112 | 7 | 63d4226a8b59f648bdc9f41e4b2d750dfa342034 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-07 | 192 | 112 | 7 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-07 | 192 | 112 | 7 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 5.94e-07 | 193 | 112 | 7 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.15e-07 | 194 | 112 | 7 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.36e-07 | 195 | 112 | 7 | 10fa47bdcf6c9784ea930b75a5861e139421feed | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.36e-07 | 195 | 112 | 7 | 9016a44b521214546a55a822ebdef5b5312206d2 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-07 | 195 | 112 | 7 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.58e-07 | 196 | 112 | 7 | b6226163d9fc93ecfff2115bb74408303a000490 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.58e-07 | 196 | 112 | 7 | a90c76d9c57a4491b94a321ba541b792ec5d8e83 | |
| ToppCell | BL-critical-LOC-Myeloid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.81e-07 | 197 | 112 | 7 | 932a7fae4979b561688e6222505df0f4e510ab11 | |
| ToppCell | (3)_Macrophage_MARCOneg|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.81e-07 | 197 | 112 | 7 | b0ee2ce1179b60b4542559acb300a34295277dbc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-07 | 197 | 112 | 7 | dc56bb758c7c5bd151be66f8f3b7078d085f72c7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-07 | 197 | 112 | 7 | 2efb5acd56b96e5afd8d72b927f1d53cc443766f | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.81e-07 | 197 | 112 | 7 | 4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.81e-07 | 197 | 112 | 7 | 7870c0651caefb0ed13d9f9dab43b5f24d6a9efc | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.05e-07 | 198 | 112 | 7 | 9b29232c8b4dcbd81f450f47c3f79bf26c8fb583 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.29e-07 | 199 | 112 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.54e-07 | 200 | 112 | 7 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Sigmoid-Macrophage|Sigmoid / Region, Cell class and subclass | 7.54e-07 | 200 | 112 | 7 | b07ac0ff3b8530e99094678fed80f35949cafac8 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.54e-07 | 200 | 112 | 7 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | Sigmoid-(6)_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 7.54e-07 | 200 | 112 | 7 | 9e10cca4429de2c4c8c3c6cf2c9e28637a095be9 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue | 2.05e-06 | 148 | 112 | 6 | de35eeefad0e27a0d127e2e4bedead2bddb75152 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-06 | 149 | 112 | 6 | 13b445c13bb8f31ff0876addd1baf969ae220ea3 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-06 | 155 | 112 | 6 | 5fabe24a784f0be46040ffc886eabd8d5ce78121 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 160 | 112 | 6 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 160 | 112 | 6 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Control / Condition, Lineage and Cell class | 4.13e-06 | 167 | 112 | 6 | ab6029ba037b6a499da8758864c44e174cde5587 | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 4.13e-06 | 167 | 112 | 6 | 6e5140527437193f441ca96893b9a00d346614f3 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 4.27e-06 | 168 | 112 | 6 | d02eba7ece17edcdd47fd6b784c93910ce61090f | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-06 | 171 | 112 | 6 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-06 | 171 | 112 | 6 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.06e-06 | 173 | 112 | 6 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | Epithelial-Epithelial-C_(AT2)|Epithelial / shred on cell class and cell subclass (v4) | 5.06e-06 | 173 | 112 | 6 | f57cbf5bd2a9e5db47b4919e9cd5e50781c1a990 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.23e-06 | 174 | 112 | 6 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | Monocytes-IFN-activated_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.58e-06 | 176 | 112 | 6 | 6a4b403ee3e4dc4f23fbd7a154011e41fd429a9e | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.58e-06 | 176 | 112 | 6 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Macrophage|GI_small-bowel / Manually curated celltypes from each tissue | 5.58e-06 | 176 | 112 | 6 | 4be270f6bb7da4070f972aca403109751646d155 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.58e-06 | 176 | 112 | 6 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-06 | 177 | 112 | 6 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-06 | 177 | 112 | 6 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.96e-06 | 178 | 112 | 6 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.35e-06 | 180 | 112 | 6 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 6.35e-06 | 180 | 112 | 6 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.56e-06 | 181 | 112 | 6 | 1aebb62ed4439db444ee9d30688212b86ee3d9ef | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.56e-06 | 181 | 112 | 6 | 6aee2ddee4790250ef3b2ef0038bd9839925c995 | |
| ToppCell | PCW_10-12-Neuronal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.56e-06 | 181 | 112 | 6 | 381b553e2cae65ce6be100662a5f9f963353840c | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.77e-06 | 182 | 112 | 6 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.77e-06 | 182 | 112 | 6 | 9966f42c338cbd471efa8ffc765a6ce93693aa75 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-06 | 183 | 112 | 6 | 8330c39184ce076e1f95fd3725b68af551d89db0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.43e-06 | 185 | 112 | 6 | fd51fef8c69e34c72017d8371ab0a0d7be5701f2 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.43e-06 | 185 | 112 | 6 | bea26e369ae91006052b973cd89b4c49afa9e553 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.43e-06 | 185 | 112 | 6 | 492529121cb9e88bd3c0db6b54af3cd2979572bc | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.66e-06 | 186 | 112 | 6 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-06 | 186 | 112 | 6 | ea936e66ae4b7b40564711fad60ac0137327995f | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.66e-06 | 186 | 112 | 6 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.90e-06 | 187 | 112 | 6 | 6ab51e17a7782c2ae6394cad813dc3a2cde70c89 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.90e-06 | 187 | 112 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 187 | 112 | 6 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 187 | 112 | 6 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 187 | 112 | 6 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 187 | 112 | 6 | a0bd2b0ec9e73521c245037b1dd51ff8cf24cbf5 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 187 | 112 | 6 | f2af79a20438108c814a73f9e24cd986d537237f | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.90e-06 | 187 | 112 | 6 | e176b5b051690f840f3b12c8f7c4cc10cbe2bbae | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-Early_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.14e-06 | 188 | 112 | 6 | 6151051c027c7ff7d5d4bf5f1e11d7fe58eb22ed | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.14e-06 | 188 | 112 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.14e-06 | 188 | 112 | 6 | 9655a4c47b644a870017d349b99063e17dbae572 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.14e-06 | 188 | 112 | 6 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.14e-06 | 188 | 112 | 6 | 562f5984efdbbcb8f53ddcee033ccbf9eb678425 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.39e-06 | 189 | 112 | 6 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.39e-06 | 189 | 112 | 6 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.39e-06 | 189 | 112 | 6 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.39e-06 | 189 | 112 | 6 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.39e-06 | 189 | 112 | 6 | d0c7549be4f77520c23dddf4f94d0fcad0081e37 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.39e-06 | 189 | 112 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | (2)_Fibroblasts-(22)_Fibro-3|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.65e-06 | 190 | 112 | 6 | 3aed03b87ba2c8d479048c3ceef3ff5e38746c28 | |
| Computational | Genes in the cancer module 46. | 7.30e-05 | 394 | 74 | 11 | MODULE_46 | |
| Computational | Immune response. | 7.99e-05 | 398 | 74 | 11 | MODULE_75 | |
| Computational | Genes in the cancer module 236. | 2.37e-04 | 18 | 74 | 3 | MODULE_236 | |
| Computational | Metal / Ca ion binding. | 2.98e-04 | 133 | 74 | 6 | MODULE_324 | |
| Computational | Genes in the cancer module 121. | 5.83e-04 | 99 | 74 | 5 | MODULE_121 | |
| Drug | monatepil | 4.81e-09 | 29 | 110 | 6 | CID000060810 | |
| Drug | probucol | 6.40e-09 | 162 | 110 | 10 | CID000004912 | |
| Drug | 25-hydroxycholesterol | 8.45e-08 | 160 | 110 | 9 | CID000065094 | |
| Drug | LMWH | FN1 SPOCK1 LAMA2 FNDC3A EXTL1 LDLR ADCY8 SCARF1 PTN EGFR LRP1 LRP2 PAPPA FGG FST | 7.14e-07 | 663 | 110 | 15 | CID000000772 |
| Drug | Calpain inhibitor I | 1.07e-06 | 280 | 110 | 10 | CID000004332 | |
| Drug | pitavastatin | 1.36e-06 | 114 | 110 | 7 | CID005282451 | |
| Drug | troglitazone | VLDLR FN1 SCARF2 CAPN3 FNDC3A LRP1B LDLR GFPT1 SCARF1 LRP1 LRP2 FST SORL1 | 1.58e-06 | 526 | 110 | 13 | CID000005591 |
| Drug | iodide | CYBB VLDLR FN1 FNDC3A TRIM24 LDLR ADCY8 SCARF1 LIMS1 EGFR LRP1 LRP2 FGG | 1.87e-06 | 534 | 110 | 13 | CID000024841 |
| Drug | epicholesterol | NPC1 VLDLR SCARF2 LRP1B LDLR GFPT1 ADCY8 SCARF1 EGFR CBFA2T2 LRP1 LRP2 FGG SORL1 | 2.38e-06 | 636 | 110 | 14 | CID000000304 |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.72e-06 | 188 | 110 | 8 | 4835_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; HL60; HT_HG-U133A | 5.25e-06 | 197 | 110 | 8 | 1871_UP | |
| Drug | sterol | 5.71e-06 | 265 | 110 | 9 | CID000001107 | |
| Drug | ezetimibe | 7.40e-06 | 147 | 110 | 7 | CID000150311 | |
| Drug | rhamnose | 9.04e-06 | 356 | 110 | 10 | CID000000840 | |
| Drug | Succimer | CYBB USP18 VLDLR MBTD1 FN1 CAPN3 GAS6 NAIP LDLRAD3 ITGB7 CD209 LIMS1 NLRP10 EGFR CBFA2T2 JAG1 LRP1 PAPPA SORL1 | 9.43e-06 | 1264 | 110 | 19 | ctd:D004113 |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A | 1.29e-05 | 160 | 110 | 7 | 6133_DN | |
| Drug | Magnetite Nanoparticles | CYBB USP18 VLDLR MBTD1 FN1 CAPN3 GAS6 NAIP LDLRAD3 ITGB7 CD209 LIMS1 NLRP10 EGFR CBFA2T2 JAG1 LRP1 PAPPA SORL1 | 1.56e-05 | 1310 | 110 | 19 | ctd:D058185 |
| Drug | N-acetylhexosamine | 1.82e-05 | 472 | 110 | 11 | CID000000899 | |
| Drug | Arg-tyr-asp | 2.34e-05 | 12 | 110 | 3 | CID000131136 | |
| Drug | sodium cholate | 2.92e-05 | 408 | 110 | 10 | CID000000303 | |
| Drug | Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.96e-05 | 182 | 110 | 7 | 5292_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 2.96e-05 | 182 | 110 | 7 | 998_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 3.28e-05 | 185 | 110 | 7 | 831_UP | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; HL60; HT_HG-U133A | 4.02e-05 | 191 | 110 | 7 | 6136_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; PC3; HT_HG-U133A | 4.02e-05 | 191 | 110 | 7 | 4298_DN | |
| Drug | Epi Lovastatin | 4.20e-05 | 341 | 110 | 9 | CID000003962 | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; PC3; HT_HG-U133A | 4.30e-05 | 193 | 110 | 7 | 6623_UP | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 4.44e-05 | 194 | 110 | 7 | 3168_DN | |
| Drug | Dapsone [80-08-0]; Up 200; 16.2uM; HL60; HT_HG-U133A | 4.44e-05 | 194 | 110 | 7 | 1868_UP | |
| Drug | PF-00875133-00 [351322-64-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.59e-05 | 195 | 110 | 7 | 5967_DN | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 4.59e-05 | 195 | 110 | 7 | 1532_DN | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; PC3; HT_HG-U133A | 4.74e-05 | 196 | 110 | 7 | 5771_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A | 4.74e-05 | 196 | 110 | 7 | 1151_UP | |
| Drug | Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A | 4.74e-05 | 196 | 110 | 7 | 6715_UP | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 4.74e-05 | 196 | 110 | 7 | 6782_DN | |
| Drug | Nifurthiazole | 4.79e-05 | 15 | 110 | 3 | CID003607071 | |
| Drug | Domperidone maleate; Down 200; 7.4uM; PC3; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 4640_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; MCF7; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 4968_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; PC3; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 6741_DN | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 6787_DN | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 3182_DN | |
| Drug | Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 4498_DN | |
| Drug | Doxylamine succinate [562-10-7]; Up 200; 10.2uM; PC3; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 4235_UP | |
| Drug | 17alpha-estradiol | VLDLR FN1 SCARF2 FNDC3A LRP1B LDLR GFPT1 ADCY8 SCARF1 PPP2R2C EGFR JAG1 LRP1 LRP2 PAPPA FGG FST SORL1 | 5.08e-05 | 1303 | 110 | 18 | CID000000450 |
| Drug | H2O2 | CYBB FN1 PPP2R2D SCARF2 GAS6 FNDC3A NCF2 TXNDC17 LDLR ADCY8 SCARF1 PPP2R2B PPP2R2C EGFR NFKBIB FGG FST | 5.19e-05 | 1183 | 110 | 17 | CID000000784 |
| Drug | Norfloxacin [70458-96-7]; Up 200; 12.6uM; HL60; HG-U133A | 5.22e-05 | 199 | 110 | 7 | 1406_UP | |
| Drug | Ciprofibrate [52214-84-3]; Down 200; 13.8uM; PC3; HT_HG-U133A | 5.22e-05 | 199 | 110 | 7 | 5740_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; HL60; HG-U133A | 5.22e-05 | 199 | 110 | 7 | 2045_DN | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A | 5.39e-05 | 200 | 110 | 7 | 6450_UP | |
| Drug | U-320 | 6.92e-05 | 3 | 110 | 2 | CID000077162 | |
| Drug | dibenzyl-N,N-diethylphosphoramidite | 7.22e-05 | 89 | 110 | 5 | CID005066231 | |
| Drug | AC1L9LHO | 7.84e-05 | 47 | 110 | 4 | CID000448003 | |
| Drug | Biomer | 8.49e-05 | 18 | 110 | 3 | CID003085227 | |
| Drug | AC1L4UUJ | 8.49e-05 | 18 | 110 | 3 | CID000164475 | |
| Drug | mangrove | 9.17e-05 | 468 | 110 | 10 | CID000000965 | |
| Drug | AC1L1GUQ | 1.00e-04 | 50 | 110 | 4 | CID000003849 | |
| Drug | simvastatin | 1.17e-04 | 390 | 110 | 9 | CID000054454 | |
| Drug | isocycloheximide | NPC1 USP18 FN1 SCARF2 LAMA2 FNDC3A LRP1B LDLR ADCY8 EGFR NFKBIB LRP1 LRP2 SORL1 | 1.18e-04 | 905 | 110 | 14 | CID000002900 |
| Drug | delta-(l-alpha-aminoadipoyl)-l-cysteinyl-glycine | 1.26e-04 | 229 | 110 | 7 | CID004369448 | |
| Drug | 8-Bromo Cyclic Adenosine Monophosphate | VLDLR ZNF486 FN1 KRT34 NCF2 TRIM24 LDLR SLCO4C1 EGFR JAG1 PAPPA ZNF454 | 1.33e-04 | 693 | 110 | 12 | ctd:D015124 |
| Drug | Lidocaine | 1.38e-04 | 4 | 110 | 2 | DB00281 | |
| Drug | SF-6,5 | 1.38e-04 | 4 | 110 | 2 | CID000126860 | |
| Drug | AC1L1J6H | 1.51e-04 | 236 | 110 | 7 | CID000004889 | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.57e-04 | 166 | 110 | 6 | 1053_UP | |
| Drug | PVLA | 1.58e-04 | 22 | 110 | 3 | CID000126094 | |
| Drug | Niclosamide [50-65-7]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.68e-04 | 168 | 110 | 6 | 4018_UP | |
| Drug | Rges Peptide | 1.81e-04 | 23 | 110 | 3 | CID000121927 | |
| Drug | Cycloheximide [66-81-9]; Down 200; 14.2uM; HL60; HT_HG-U133A | 1.85e-04 | 171 | 110 | 6 | 2723_DN | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 2.03e-04 | 174 | 110 | 6 | 864_UP | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 2.03e-04 | 174 | 110 | 6 | 972_UP | |
| Drug | TTEGDA | 2.29e-04 | 5 | 110 | 2 | CID000028803 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 2.29e-04 | 178 | 110 | 6 | 916_UP | |
| Drug | AC1L320U | 2.34e-04 | 25 | 110 | 3 | CID000133020 | |
| Drug | C12063 | 2.39e-04 | 429 | 110 | 9 | CID005282055 | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A | 2.66e-04 | 183 | 110 | 6 | 6946_UP | |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; HL60; HT_HG-U133A | 2.74e-04 | 184 | 110 | 6 | 1321_DN | |
| Drug | sodium chloride | FN1 SPOCK1 SFTPD GNPTAB CAPN3 FNDC3A GBA2 CD209 EGFR UMOD FGG POFUT2 SLC37A4 | 2.78e-04 | 865 | 110 | 13 | CID000000206 |
| Drug | Cd-B | 2.78e-04 | 65 | 110 | 4 | CID000447221 | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; PC3; HT_HG-U133A | 2.82e-04 | 185 | 110 | 6 | 1215_UP | |
| Drug | vitamin E | 2.92e-04 | 441 | 110 | 9 | CID000002116 | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.17e-04 | 189 | 110 | 6 | 1700_UP | |
| Drug | Cycloheximide | 3.17e-04 | 446 | 110 | 9 | ctd:D003513 | |
| Drug | canola oil | 3.18e-04 | 122 | 110 | 5 | ctd:C061996 | |
| Drug | Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; HL60; HG-U133A | 3.26e-04 | 190 | 110 | 6 | 1396_UP | |
| Drug | oxaprozin; Up 200; 300uM; MCF7; HT_HG-U133A_EA | 3.26e-04 | 190 | 110 | 6 | 863_UP | |
| Drug | F 155 | 3.43e-04 | 6 | 110 | 2 | CID003028671 | |
| Drug | F 29 | 3.43e-04 | 6 | 110 | 2 | CID006419426 | |
| Drug | ethylene acrylic acid | 3.43e-04 | 6 | 110 | 2 | CID000062701 | |
| Drug | conduritol aziridine | 3.43e-04 | 6 | 110 | 2 | CID000130051 | |
| Drug | AC1NSXES | 3.43e-04 | 6 | 110 | 2 | CID005318890 | |
| Drug | Deptropine citrate [2169-75-7]; Up 200; 7.6uM; PC3; HT_HG-U133A | 3.44e-04 | 192 | 110 | 6 | 5118_UP | |
| Drug | Clemastine fumarate [14976-57-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 3.44e-04 | 192 | 110 | 6 | 7485_UP | |
| Drug | Mesalamine [89-57-6]; Down 200; 26.2uM; HL60; HT_HG-U133A | 3.44e-04 | 192 | 110 | 6 | 6162_DN | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; PC3; HG-U133A | 3.54e-04 | 193 | 110 | 6 | 1896_UP | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.54e-04 | 193 | 110 | 6 | 5273_DN | |
| Drug | Thiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.54e-04 | 193 | 110 | 6 | 2894_DN | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 3.64e-04 | 194 | 110 | 6 | 6673_UP | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.64e-04 | 194 | 110 | 6 | 3422_UP | |
| Drug | Benzethonium chloride [121-54-0]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.64e-04 | 194 | 110 | 6 | 6070_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.64e-04 | 194 | 110 | 6 | 4417_DN | |
| Disease | Glioblastoma Multiforme | 3.11e-06 | 111 | 106 | 6 | C1621958 | |
| Disease | Alzheimer's disease (is_implicated_in) | 8.46e-06 | 132 | 106 | 6 | DOID:10652 (is_implicated_in) | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 9.68e-06 | 12 | 106 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | Glioblastoma | 9.93e-06 | 79 | 106 | 5 | C0017636 | |
| Disease | Hepatic ductular hypoplasia | 1.28e-05 | 2 | 106 | 2 | C2930797 | |
| Disease | Alagille syndrome (is_implicated_in) | 1.28e-05 | 2 | 106 | 2 | DOID:9245 (is_implicated_in) | |
| Disease | Alagille Syndrome 2 | 1.28e-05 | 2 | 106 | 2 | C1857761 | |
| Disease | Alagille Syndrome 1 | 1.28e-05 | 2 | 106 | 2 | C1956125 | |
| Disease | Alagille Syndrome | 1.28e-05 | 2 | 106 | 2 | C0085280 | |
| Disease | Arteriohepatic dysplasia | 1.28e-05 | 2 | 106 | 2 | cv:C0085280 | |
| Disease | Giant Cell Glioblastoma | 1.34e-05 | 84 | 106 | 5 | C0334588 | |
| Disease | corpus callosum volume measurement | 3.12e-05 | 100 | 106 | 5 | EFO_0010299 | |
| Disease | four-jointed box protein 1 measurement | 3.83e-05 | 3 | 106 | 2 | EFO_0801605 | |
| Disease | corpus collosum mid-posterior volume measurement | 9.78e-05 | 25 | 106 | 3 | EFO_0010300 | |
| Disease | cystatin C measurement | 1.04e-04 | 402 | 106 | 8 | EFO_0004617 | |
| Disease | Chronic granulomatous disease | 1.27e-04 | 5 | 106 | 2 | cv:C0018203 | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.07e-04 | 32 | 106 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma of lung | 2.07e-04 | 32 | 106 | 3 | C0149782 | |
| Disease | cervical cancer | 2.49e-04 | 34 | 106 | 3 | C4048328 | |
| Disease | temporal arteritis (is_marker_for) | 2.65e-04 | 7 | 106 | 2 | DOID:13375 (is_marker_for) | |
| Disease | adenocarcinoma (implicated_via_orthology) | 2.65e-04 | 7 | 106 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 2.65e-04 | 7 | 106 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | Uterine Cervical Neoplasm | 2.71e-04 | 35 | 106 | 3 | C0007873 | |
| Disease | cervical cancer (is_marker_for) | 2.95e-04 | 36 | 106 | 3 | DOID:4362 (is_marker_for) | |
| Disease | Scoliosis, unspecified | 3.53e-04 | 8 | 106 | 2 | C0036439 | |
| Disease | Squamous cell carcinoma of esophagus | 3.90e-04 | 95 | 106 | 4 | C0279626 | |
| Disease | obsolete aging | 5.24e-04 | 279 | 106 | 6 | GO_0007568 | |
| Disease | white matter microstructure measurement | 5.30e-04 | 390 | 106 | 7 | EFO_0005674 | |
| Disease | urinary 6‑hydroxymelatonin sulfate to creatinine ratio | 5.65e-04 | 10 | 106 | 2 | EFO_0021488 | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 6.11e-04 | 46 | 106 | 3 | EFO_0005325, HP_0012735 | |
| Disease | Mammary Carcinoma, Human | 6.25e-04 | 525 | 106 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 6.25e-04 | 525 | 106 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 6.41e-04 | 527 | 106 | 8 | C1458155 | |
| Disease | systemic lupus erythematosus (is_marker_for) | 6.51e-04 | 47 | 106 | 3 | DOID:9074 (is_marker_for) | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 6.88e-04 | 11 | 106 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | Congenital Abnormality | 6.88e-04 | 11 | 106 | 2 | C0000768 | |
| Disease | Breast Carcinoma | 7.33e-04 | 538 | 106 | 8 | C0678222 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 7.36e-04 | 49 | 106 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 7.81e-04 | 50 | 106 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | brain disease (is_implicated_in) | 8.24e-04 | 12 | 106 | 2 | DOID:936 (is_implicated_in) | |
| Disease | Obesity | 8.85e-04 | 205 | 106 | 5 | C0028754 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.30e-03 | 15 | 106 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.30e-03 | 15 | 106 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.30e-03 | 15 | 106 | 2 | C0154091 | |
| Disease | diet measurement | BRINP3 PPP2R2D ADAM23 LAMA2 LRP1B SYT10 LDLR NELL1 ZFHX3 ZNF345 SORL1 | 1.39e-03 | 1049 | 106 | 11 | EFO_0008111 |
| Disease | Synostotic Posterior Plagiocephaly | 1.48e-03 | 16 | 106 | 2 | C1833340 | |
| Disease | Craniosynostosis, Type 1 | 1.48e-03 | 16 | 106 | 2 | C4551902 | |
| Disease | Acrocephaly | 1.48e-03 | 16 | 106 | 2 | C0030044 | |
| Disease | Trigonocephaly | 1.48e-03 | 16 | 106 | 2 | C0265535 | |
| Disease | Scaphycephaly | 1.48e-03 | 16 | 106 | 2 | C0265534 | |
| Disease | Synostotic Anterior Plagiocephaly | 1.48e-03 | 16 | 106 | 2 | C2931150 | |
| Disease | Metopic synostosis | 1.48e-03 | 16 | 106 | 2 | C1860819 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.62e-03 | 139 | 106 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 1.66e-03 | 140 | 106 | 4 | C0005695 | |
| Disease | Malignant neoplasm of breast | FN1 SCARF2 RPS8 LAMA2 DLL1 EGFR JAG1 FST NOTCH1 NOTCH2 SORL1 | 1.68e-03 | 1074 | 106 | 11 | C0006142 |
| Disease | muscular dystrophy (is_implicated_in) | 1.68e-03 | 17 | 106 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Brachycephaly | 1.68e-03 | 17 | 106 | 2 | C0221356 | |
| Disease | Malignant neoplasm of urinary bladder | 1.70e-03 | 141 | 106 | 4 | C0005684 | |
| Disease | Alcohol abuse | 1.83e-03 | 67 | 106 | 3 | C0085762 | |
| Disease | type 1 diabetes mellitus | 1.84e-03 | 242 | 106 | 5 | MONDO_0005147 | |
| Disease | Carcinoma of bladder | 1.88e-03 | 18 | 106 | 2 | C0699885 | |
| Disease | maximum cigarettes per day measurement | 1.88e-03 | 18 | 106 | 2 | EFO_0009264 | |
| Disease | body fat percentage | 1.94e-03 | 488 | 106 | 7 | EFO_0007800 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.05e-03 | 364 | 106 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | anorexia nervosa | 2.07e-03 | 70 | 106 | 3 | MONDO_0005351 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 2.10e-03 | 19 | 106 | 2 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 2.10e-03 | 19 | 106 | 2 | C1843181 | |
| Disease | cerebral infarction (is_marker_for) | 2.10e-03 | 19 | 106 | 2 | DOID:3526 (is_marker_for) | |
| Disease | Cardio-facio-cutaneous syndrome | 2.10e-03 | 19 | 106 | 2 | C1275081 | |
| Disease | Costello syndrome (disorder) | 2.10e-03 | 19 | 106 | 2 | C0587248 | |
| Disease | Craniosynostosis | 2.33e-03 | 20 | 106 | 2 | C0010278 | |
| Disease | Craniofacial Abnormalities | 2.46e-03 | 156 | 106 | 4 | C0376634 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.52e-03 | 75 | 106 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Lung Neoplasms | 2.73e-03 | 265 | 106 | 5 | C0024121 | |
| Disease | Malignant neoplasm of lung | 2.77e-03 | 266 | 106 | 5 | C0242379 | |
| Disease | LEOPARD Syndrome | 2.82e-03 | 22 | 106 | 2 | C0175704 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 3.03e-03 | 80 | 106 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | clinical and behavioural ideal cardiovascular health | 3.08e-03 | 23 | 106 | 2 | EFO_0007654 | |
| Disease | creatinine measurement | 3.12e-03 | 995 | 106 | 10 | EFO_0004518 | |
| Disease | congenital heart disease (is_implicated_in) | 3.35e-03 | 24 | 106 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | Carcinoma, Pancreatic Ductal | 3.35e-03 | 24 | 106 | 2 | C0887833 | |
| Disease | Noonan Syndrome | 3.35e-03 | 24 | 106 | 2 | C0028326 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DIVQCFSCGGCLEKW | 311 | Q13075 | |
| FSCGGCLEKWQEGDD | 316 | Q13075 | |
| QQCEDKWGHLCALAD | 1051 | P40145 | |
| NSEGEFICKENDCWC | 266 | Q76B58 | |
| DCIFDKFECVWNGSD | 336 | Q00005 | |
| DCIFDKFECAWNGSD | 336 | Q9Y2T4 | |
| CQKICDQWDNLGALT | 476 | P12814 | |
| EKGNCGKDGDRWIQC | 636 | O75077 | |
| GDWFCTVCLAQQVEG | 1716 | Q9UIF9 | |
| SGWVQCSKQDVLCGF | 586 | O75078 | |
| DCIFDKFECCWNGSD | 346 | Q66LE6 | |
| CAEFSGNGWNDDKCN | 356 | Q9NNX6 | |
| QWPQSQKDACGEEGC | 356 | Q6P1W5 | |
| WNNAAADVVCKQLGC | 291 | Q9NR16 | |
| GQWDCSACLVQNEGS | 1481 | P49792 | |
| ECTCQVGFTGKECQW | 91 | Q7Z3S9 | |
| VGFTGKECQWTDACL | 96 | Q7Z3S9 | |
| GAECKYQFQAWGECD | 96 | P21246 | |
| ENEGQKCELWLCGCA | 251 | Q96MZ0 | |
| KVWCRNNSGEEFDCA | 586 | Q08J23 | |
| GFTGKECQWTDACLS | 136 | P0DPK3 | |
| GFTGKECQWTDACLS | 136 | Q04721 | |
| CVNGWSGDDCSENID | 326 | Q04721 | |
| VDGSCTCKEGWQGLD | 461 | A6BM72 | |
| NCAWCEDGVFTSNEK | 76 | Q6A162 | |
| AWQCDGLPDCFDKSD | 46 | Q86YD5 | |
| ACGWDGGDCSLNFND | 1471 | P46531 | |
| GGDCSLNFNDPWKNC | 1476 | P46531 | |
| KRWLCDGANDCGSNE | 901 | Q9NZR2 | |
| LNTWICDGQKDCEDG | 2696 | Q9NZR2 | |
| CLTLWCENTVGDQGF | 421 | P19878 | |
| GFENDSGLDFWCNIC | 211 | Q05BQ5 | |
| NQGCANSWLADKFCD | 506 | Q3T906 | |
| CVECWANSEENDTKG | 516 | Q9H3C7 | |
| ESKLEQLLFWCCGDN | 216 | Q86W26 | |
| ARCISKAWVCDGDND | 1116 | Q07954 | |
| NMLWCNGADDCGDGS | 2581 | Q07954 | |
| HFQCDCWLSKSEGDG | 1776 | Q8IVV2 | |
| CLKGSQWSDIEEFCN | 81 | P08174 | |
| CLGKAADADEWCDSG | 6 | Q15653 | |
| EESTENCWNCGRKAS | 501 | O43439 | |
| LHNTTGFWCENCLEG | 426 | Q9H1U4 | |
| NLQEDNWKGCDECFC | 506 | P24043 | |
| WNFREKEGDCKGCTV | 2316 | P24043 | |
| YQNWVCDGEDDCKDN | 236 | P98164 | |
| DDCGDWSDELGCNKG | 3951 | P98164 | |
| EDIQCTGGKKCLWDF | 246 | P19883 | |
| KTQCTQDGSWQEGAC | 1396 | Q13219 | |
| ECTCQVGFTGKECQW | 91 | P0DPK4 | |
| VGFTGKECQWTDACL | 96 | P0DPK4 | |
| AEGPKCGENSECKNW | 396 | Q92832 | |
| CSWANVKEEVAGQCQ | 206 | Q7Z442 | |
| CAWCKQLNFTASGEA | 61 | P26010 | |
| LCGKDADACNATNWI | 176 | O15118 | |
| DKFEGNCAEQDGSGW | 346 | P02679 | |
| TCCTDWGQFFLIQEK | 241 | O43826 | |
| NGSCWGAGEENCQKL | 196 | P00533 | |
| DVCQGSLGNCWFLAA | 96 | Q6ZSI9 | |
| NNKGTGCEFELWDCG | 51 | Q9H7X7 | |
| SDQCAGQWFLKACGL | 751 | Q9HCG7 | |
| CQEGWGGLFCNQDLN | 276 | O00548 | |
| GEQWQKEYLGAICSC | 2396 | P02751 | |
| LEWDEGKGNGEFCQC | 406 | Q9Y2H6 | |
| AGWGGRLCDKDVNEC | 146 | Q14393 | |
| WTEGLFNACGCDKQE | 361 | P04839 | |
| FNACGCDKQEFQDAW | 366 | P04839 | |
| SAGGDDCSLFVWKCV | 1951 | Q05BV3 | |
| LTSGKACEEVQWCGF | 916 | P82279 | |
| ANRTDICQGELGDCW | 116 | P20807 | |
| DVGNFSWGSECCTRK | 61 | P62241 | |
| NWTSGFNKCAVGAAC | 161 | P15328 | |
| QCLCETNWGGQLCDK | 281 | P78504 | |
| DGVNSYKCICSDGWE | 646 | P78504 | |
| VNGESFTCVCKEGWE | 761 | P78504 | |
| FKQVDDLASVWCQCG | 426 | Q9HCS7 | |
| PNWKRCDGHQDCQDG | 1486 | Q92673 | |
| NEDWCAVCQNGGDLL | 886 | Q9UPN9 | |
| LDVDNSCDWALGVCN | 341 | Q96BQ3 | |
| EWDAENQGSFCNGCK | 386 | Q6NUJ1 | |
| NIDGWEGKDIGQCCN | 426 | Q07890 | |
| GFDGGNDKDWEANAC | 41 | Q06210 | |
| CNWFCEGSFNGSEKE | 86 | O76011 | |
| GDNPWECDCNLREFK | 196 | Q8N967 | |
| FCGDQEKACEQPTHW | 411 | Q9Y2G5 | |
| WRFSCCQVNIESGKG | 1161 | Q15858 | |
| GDVVSALNKAWCVNC | 261 | P48059 | |
| GWEGKDIGQCCNEFI | 431 | Q07889 | |
| NWESCFDTSKCRGDG | 81 | Q92935 | |
| SAELQCCAGWRQKDQ | 36 | Q14162 | |
| CFGTKKSQCLWENED | 236 | Q5VX52 | |
| ELNYWACKGEGEICV | 496 | Q9UKU0 | |
| EANGFCVECVEWLCK | 171 | O15164 | |
| CLWDASVQVKACAGG | 256 | P07911 | |
| EKCCFWVNQSGKVQD | 436 | P60508 | |
| CVEIFTNGKWNDRAC | 351 | P35247 | |
| DINDCGIKGACWIYD | 646 | Q6ZQN7 | |
| ECNWAGKDIGTECMN | 101 | Q13214 | |
| NEEQAWAVCFQGCRG | 36 | Q8WWL2 | |
| NAGWIGDRCETKCSN | 351 | Q96GP6 | |
| IAWECPEKNCAQGEG | 366 | Q9C0C9 | |
| CEECGKAFSWVSVLN | 566 | P0DKX0 | |
| STGQCWCVDKYGNEL | 351 | Q08629 | |
| ECWLFDCGEGTQTQL | 31 | Q9H777 | |
| AKCSGDCGFTWDSNI | 1051 | Q86WI1 | |
| QDFKCCGSNSSADWQ | 151 | A1L157 | |
| TELCFAGQVEWEKCS | 21 | Q6XYQ8 | |
| DAGGKSWCPDCVQAE | 36 | Q9BRA2 | |
| AVDGKWFCFNDSNIC | 326 | Q3LFD5 | |
| KCEECGKAFNWSSNL | 426 | O43345 | |
| KCEECGKAFNWSSNL | 1086 | O43345 | |
| KCEECGKGFGWSVNL | 381 | Q86WZ6 | |
| KCASLLEWQCGGQEI | 121 | Q8N9F8 | |
| CFSFQETDKAWHGGC | 406 | Q9BTW9 | |
| LDVDNSCDWALGVCN | 341 | A6NCK2 | |
| AVDGKWFCFNDSNIC | 326 | Q9UMW8 | |
| CSSFRGDWECKNQFE | 11 | Q14585 | |
| SWNKEQGFIACGGED | 21 | Q9P2L0 | |
| CKECGKAFNWSSDLN | 436 | Q96H40 | |
| LGWVEQAYADKCVCG | 41 | O95411 | |
| ECGECGKTFWEKSNL | 381 | Q8NDW4 | |
| WKGACNGSVDCEDTT | 216 | Q6X784 | |
| ICSECGQGFIWKSNL | 601 | Q9Y3M9 | |
| EDSGFICWKKGCNQV | 1356 | Q15911 | |
| SGKNWCEEDMENGGC | 701 | P98155 | |
| GAGALQCDLCQDWFH | 1196 | P41229 | |
| SYKWVCDGSAECQDG | 41 | P01130 |